INNO-GENE SA ZY -10 (WQ3) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.003x

Based on the latest financial reports, INNO-GENE SA ZY -10 (WQ3) has a cash flow conversion efficiency ratio of 0.003x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€54.00K ≈ $63.13K USD) by net assets (€17.55 Million ≈ $20.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of INNO-GENE SA ZY -10 for the company's overall valuation and market capitalisation.

INNO-GENE SA ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how INNO-GENE SA ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data.

INNO-GENE SA ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INNO-GENE SA ZY -10 ranked by their cash flow conversion efficiency. Explore WQ3 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
BIFIDO Co. Ltd KQ:238200	-0.001x
Cocrystal Pharma Inc NASDAQ:COCP	-0.569x
COSMOS HEALTH NEW DL-01 F:V67A	-0.249x
IntegraFin Holdings plc LSE:IHP	1.676x
Applied Therapeutics Inc NASDAQ:APLT	32.800x
Dome Gold Mines Ltd AU:DME	-0.023x
Paterson Resources Ltd AU:PSL	0.000x
iRobot Corporation NASDAQ:IRBT	1.770x

Annual Cash Flow Conversion Efficiency for INNO-GENE SA ZY -10 (2021–2024)

The table below shows the annual cash flow conversion efficiency of INNO-GENE SA ZY -10 from 2021 to 2024. View latest INNO-GENE SA ZY -10 stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€18.02 Million ≈ $21.06 Million	€-1.13 Million ≈ $-1.32 Million	-0.063x	+93.85%
2023-12-31	€2.44 Million ≈ $2.85 Million	€-2.49 Million ≈ $-2.91 Million	-1.020x	-74759.14%
2022-12-31	€8.05 Million ≈ $9.41 Million	€11.00K ≈ $12.86K	0.001x	-99.84%
2021-12-31	€7.85 Million ≈ $9.17 Million	€6.75 Million ≈ $7.89 Million	0.861x	--

About INNO-GENE SA ZY -10

F:WQ3 Germany Specialty Chemicals

Market Cap

$14.88 Million

€12.73 Million EUR

Market Cap Rank

#26109 Global

#2240 in Germany

Share Price

€0.38

Change (1 day)

+0.00%

52-Week Range

€0.38 - €0.38

All Time High

€4.46